Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia
about
Auranofin induces apoptosis and when combined with retinoic acid enhances differentiation of acute promyelocytic leukaemia cells in vitroPerspectives of differentiation therapies of acute myeloid leukemia: the search for the molecular basis of patients' variable responses to 1,25-dihydroxyvitamin d and vitamin d analogsNovel targeted therapies for Bcr-Abl positive acute leukemias: beyond STI571.Molecular Connections between Cancer Cell Metabolism and the Tumor MicroenvironmentA review of arsenic trioxide and acute promyelocytic leukemiaArsenic induces functional re-expression of estrogen receptor α by demethylation of DNA in estrogen receptor-negative human breast cancerSynergistic effect of cell differential agent-II and arsenic trioxide on induction of cell cycle arrest and apoptosis in hepatoma cells.Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide.Oncogenomic disruptions in arsenic-induced carcinogenesis.Arsenic trioxide suppresses paclitaxel-induced mitotic arrest.Arsenic trioxide, a therapeutic agent for APL.Orchestration of multiple arrays of signal cross-talk and combinatorial interactions for maturation and cell death: another vision of t(15;17) preleukemic blast and APL-cell maturation.The PML-RARalpha fusion protein and targeted therapy for acute promyelocytic leukemia.Treatment of acute promyelocytic leukemia with arsenic trioxide: clinical and basic studies.Arsenic trioxide-mediated growth inhibition of myeloma cells is associated with an extrinsic or intrinsic signaling pathway through activation of TRAIL or TRAIL receptor 2.Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction.Targeting metabolism with arsenic trioxide and dichloroacetate in breast cancer cells.Tetraarsenictetrasulfide and Arsenic Trioxide Exert Synergistic Effects on Induction of Apoptosis and Differentiation in Acute Promyelocytic Leukemia Cells.Arsenic trioxide for the treatment of myelodysplastic syndromes.Arsenic trioxide in the treatment of haematological malignancies.The sensitivity of digestive tract tumor cells to As2O3 is associated with the inherent cellular level of reactive oxygen species.Dose-dependent effects of selenite (Se(4+)) on arsenite (As(3+))-induced apoptosis and differentiation in acute promyelocytic leukemia cells.Cytokines in the differentiation therapy of leukemia: from laboratory investigations to clinical applications.Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide.Realgar-induced apoptosis and differentiation in all-trans retinoic acid (ATRA)-sensitive NB4 and ATRA-resistant MR2 cellsLeukemia, an effective model for chemical biology and target therapy.Src Family Kinase Inhibitor PP2 Has Different Effects on All-Trans-Retinoic Acid or Arsenic Trioxide-Induced Differentiation of an Acute Promyelocytic Leukemia Cell Line.Anticancer activity of small-molecule and nanoparticulate arsenic(III) complexes.Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation.The evolving use of arsenic in pharmacotherapy of malignant disease.Arsenic trioxide-based therapy in relapsed/refractory multiple myeloma patients: a meta-analysis and systematic review.Arsenic trioxide promotes histone H3 phosphoacetylation at the chromatin of CASPASE-10 in acute promyelocytic leukemia cells.CKMT1 regulates the mitochondrial permeability transition pore in a process that provides evidence for alternative forms of the complex.Galectin-3 inhibition sensitizes human renal cell carcinoma cells to arsenic trioxide treatment.Arsenic trioxide induces apoptosis in uveal melanoma cells through the mitochondrial pathway.Arsenic trioxide-induced neuroblastoma cell death is accompanied by proteolytic activation of nuclear Bax.Ascorbate enhances the toxicity of the photodynamic action of Verteporfin in HL-60 cells.CD44 ligation induces apoptosis via caspase- and serine protease-dependent pathways in acute promyelocytic leukemia cells.Requirement for myeloid growth factors in the differentiation of acute promyelocytic leukaemia.Vitamin C protects HL60 and U266 cells from arsenic toxicity.
P2860
Q24671800-7E709B07-915F-4CA2-BCD5-4DCBC57BDDF6Q26991440-4BBC600C-F4BF-4F01-BD76-1EA98E879AD9Q27824789-EC5D3FC4-13F6-4F3F-9547-EFF9FD8874F1Q28081657-C1C26D6F-1E8D-4682-A3B1-E9F28E5AF98AQ28087768-A5FD8319-315C-4AA1-884E-79F9AFB70E44Q28482827-138DAFC2-B3A0-4098-8849-4E5E41B28590Q33185585-88463FCF-018A-4909-A20A-BA3BD46F2F60Q33291299-1D2CE81F-806B-4FCC-A827-41D4C99419B8Q33649020-08BCCDA4-3DA7-4C99-8DB2-8C356BA79624Q33665774-220ACB9B-1CDE-4760-A919-7955B62FFBC8Q34435492-90BCC008-56D3-46AE-8D2C-BBC08B0F4B10Q34435506-D913BC9A-9C68-4F76-9E58-766AC3A52295Q34548159-944A78FF-57BE-4092-AFB4-CEBDA31351FAQ34575618-105AEC6B-E2A1-4B11-A7A6-4C9658A463F1Q34616652-76D180B2-A733-4488-A602-EDF432D4BCA0Q35578134-B2B21930-4DBB-41A1-8C34-13AF75BC83D1Q35618400-5EB49CDD-5FB1-41C3-B1FA-A4A4C987A4E1Q35674537-CB81799A-7CD9-4F1B-8C33-4852C7359D4AQ35688178-586F383B-DC00-499A-9EC3-9BEC7661AD28Q35925650-A8A6B632-E627-462C-9173-EDAC0735D1AAQ36309105-7EF02ECD-6EA1-4D20-965C-0E367D1F660FQ36347135-A6991B60-05B8-4A14-AD68-146F5FCDF242Q36359510-8102E798-5AC0-4380-A0EE-2DED9690139FQ36509566-A0D0E1B9-F2BC-4FFD-AB6D-E42DD62D1832Q36645674-F13BBDFE-95EA-47AC-B663-2476EF3C2033Q36920748-EBE19F84-BD4B-404D-9B01-0F8DE74625AEQ37011134-F53439E5-497A-4C55-A827-9F73275E463CQ37486703-B1AA7795-007B-4C98-B7A8-947C9FD1F721Q37610733-2A0B607D-ADC0-47E9-84DF-56E7EC742DC3Q38089629-65D5E05C-D083-4A7E-8BBE-9B15F6A8D3A1Q38253354-E4C3755E-177D-45A2-AC91-B800A8BD52ECQ38361778-49903219-D216-4170-B411-5FD3362A52EFQ38752818-F4331A39-32F3-4C4E-A696-2B2AB729DBCAQ39114955-066C17F7-42FB-4D38-86FF-4601DFD81A68Q39634173-333CF7AF-A232-4267-BE7B-7740F168859EQ40150435-CB1162C6-A240-42BA-9CDB-09EC46128E7AQ40288747-3C52B6BA-F08A-4CFE-99DE-F7726F879610Q40365002-31DB6C05-E418-44BC-8C36-E31861BDF367Q40449095-DBF8E111-8506-4D2D-8EF8-BB84FDFBE3CAQ40464464-06A19432-0623-4161-A33A-F1CA3A95F374
P2860
Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Arsenic trioxide-induced apopt ...... n acute promyelocytic leukemia
@ast
Arsenic trioxide-induced apopt ...... n acute promyelocytic leukemia
@en
Arsenic trioxide-induced apopt ...... n acute promyelocytic leukemia
@nl
type
label
Arsenic trioxide-induced apopt ...... n acute promyelocytic leukemia
@ast
Arsenic trioxide-induced apopt ...... n acute promyelocytic leukemia
@en
Arsenic trioxide-induced apopt ...... n acute promyelocytic leukemia
@nl
prefLabel
Arsenic trioxide-induced apopt ...... n acute promyelocytic leukemia
@ast
Arsenic trioxide-induced apopt ...... n acute promyelocytic leukemia
@en
Arsenic trioxide-induced apopt ...... n acute promyelocytic leukemia
@nl
P2093
P921
P356
P1433
P1476
Arsenic trioxide-induced apopt ...... n acute promyelocytic leukemia
@en
P2093
P2888
P304
P356
10.1038/SJ.LEU.2401650
P407
P577
2000-02-01T00:00:00Z
P5875
P6179
1023338489